trial · primary record
Pridopidine
Amyotrophic Lateral Sclerosis
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 500 |
| Primary completion | 2029-03 |
| Primary endpoint | Change from baseline through Week 26 and Week 48 in the Revised ALS Functional Rating Scale (ALSFRS-R) total score adjusted for mortality |
| Registry ID | NCT07322003 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:43.104Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07322003
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.